跳至主要内容
临床试验/NCT01007799
NCT01007799已完成不适用

A Randomized, Clinical Trial of a Novel Immunotherapy for Chronic Sinusitis: Vitamin D

University of Chicago1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2009年11月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
30
试验地点
1
主要终点
score on the Sinonasal Outcome Test-22 (SNOT-22)

研究概览

简要总结

The purpose of this study is to examine if vitamin D improves the symptoms of chronic sinusitis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •African American (4 grandparents with AA ancestry)
  • •Age>18 years
  • •Diagnosis of chronic sinusitis

排除标准

  • •Women of childbearing potential not utilizing contraception
  • •Subjects with contraindications to vitamin D therapy
  • •History of nephrolithiasis, hypercalcemia, sarcoidosis, recent (3 month) hospitalization
  • •Use of immunosuppressants/medications that interfere with vitamin D metabolism (e.g., phenytoin and carbamazepine)
  • •Malignancy
  • •Kidney, gastrointestinal, or liver disorders
  • •Immunodeficiency
  • •Morbid obesity (BMI>35 kg/m2)
  • •Changes to medications for 6 months prior to study entry

研究组 & 干预措施

Placebo

Placebo Comparator

Placebo pills to take for 12 weeks

干预措施: vitamin D placebo (Dietary Supplement)

Vitamin D

Active Comparator

Vitamin D supplement for 12 weeks

干预措施: Vitamin D (Dietary Supplement)

结局指标

主要结局

score on the Sinonasal Outcome Test-22 (SNOT-22)

时间窗: study onset, mid-point and conclusion

次要结局

  • Quality of life as measured by SF-36(At entry and at completion of study)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验